
---
nice.evidencecategory: 
---

### Evidence Statement CG66ES90
The Cochrane review on antihypertensives for preventing diabetic kidney disease found NS
difference for ACEI vs placebo (three trials, N=2,683) and for ACEI vs CCBs (six trials,
N=1,286).236 These findings were supported by the Cochrane review on ACEI and A2RB for
preventing the progression of diabetic kidney disease for ACEI vs placebo (21 trials, N=7,295)*
and ACEI vs A2RB (five studies, N=3,409).237 Level 1++

[@2005]

